Cardiology Self-Assessment Program (CardSAP) Book 1: Cardiovascular Critical Care (Cert # L239231)

The target audience for Cardiology Self-Assessment Program (CardSAP) Book 1: Heart Failure is board-certified cardiology pharmacy specialists caring for patients who have developed cardiac arrhythmias and/or thromboembolic disorders.

Board certified pharmacists are eligible to receive up to 15.5 hours of recertification credit for completing this course. To earn recertification credit, learners must review the activity content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

Cardiovascular Critical Care I
ACPE #: 0217-9999-23-069-H01-P
Chapter: Acute Pulmonary Embolism

• Distinguish the differences between the drug therapy recommendations of various guidelines recommending treatment for pulmonary embolism.
• Analyze the current literature for treatment of acute pulmonary embolism, particularly high- and intermediate-risk pulmonary embolism.
• Design the most appropriate acute treatment plan for pulmonary embolism based on severity of disease, patient specific factors, and institutional resources.
• Develop an anticoagulation plan after the acute phase of pulmonary embolism including selection of anticoagulants, transitioning between anticoagulants, and duration of treatment for patients with pulmonary embolism.
• Create a treatment plan for patients with VTE in special populations including obesity, pregnancy, cancer, and COVID-19.  

Chapter: Anticoagulation Bleeding Reversal

• Classify types of bleeding and distinguish between laboratory assays to qualify and quantify the degree of anticoagulation.
• Delineate the role of specific and nonspecific reversal options in an anticoagulant-based bleeding event.
• Evaluate patient risk factors and considerations for restarting anticoagulant therapy after an anticoagulant-based bleeding event. 

Cardiovascular Critical Care II
ACPE #: 0217-9999-23-070-H01-P
Chapter: Vasoplegic Syndrome

• Distinguish pathophysiologic mechanisms for the development of vasoplegic syndrome.
• Evaluate patient-specific risk factors for the development of vasoplegic syndrome.
• Develop a mitigation strategy to prevent post-cardiopulmonary bypass-associated vasoplegic syndrome in patients who are at risk.
• Design an appropriate regimen for the treatment of vasoplegic shock based on patient- and drug-specific factors. 

Chapter: Pulmonary Hypertension in the Critically Ill

• Distinguish between the common etiologies and classifications of pulmonary hypertension.
• Design evidence-based therapeutic regimens to treat pulmonary hypertension.
• Apply strategies for supportive care in patients with decompensated pulmonary hypertension.
• Develop a multidisciplinary care plan to manage pulmonary hypertension in the ICU.  

Cardiovascular Critical Care III
ACPE #: 0217-9999-23-071-H01-P
Chapter: Transfusion and Hemostasis Management After Surgery

• Distinguish between physiologic and surgical factors contributing to postoperative bleeding.
• Design a targeted blood transfusion plan for a patient with postoperative hemorrhage.
• Design an adjunctive pharmacologic treatment plan for a patient experiencing postoperative hemorrhage 

Chapter: Pain and Delirium

• Distinguish among the etiologies of pain and how to assess pain in a critically ill patient.
• Design a comprehensive regimen for the treatment of pain and delirium while considering patient- and drug-specific factors.
• Account for special populations in the development of appropriate pain and delirium treatment regimens.
• Evaluate for risk factors and adverse effects of delirium in a critically ill patient. 

Cardiovascular Critical Care IV
ACPE #: 0217-9999-23-072-H01-P
Interactive Case: Antimicrobial Prophylaxis in Cardiac Surgery

• Evaluate patient factors and characteristics increasing the risk of surgical site infection after cardiac surgery.
• Apply evidence-based treatment principles for antimicrobial prophylaxis for an individualized patient case scenario.
• Develop a comprehensive regimen for antimicrobial prophylaxis for cardiac surgical procedures using optimal dosing strategies, administration characteristics, and therapy duration. 

Interactive Case: Surgical Blood Conservation Strategies

• Justify the use of surgical blood conservation strategies.
• Distinguish the pharmacist’s roles and responsibilities in perioperatively managing pharmacologic agents and reviewing laboratory values.
• Evaluate patients for risk of adverse events and recommend risk mitigation strategies.
• Apply the available therapeutic strategies for surgical blood conservation.

Series Editors

Cynthia A. Jackevicius, PharmD, MSc, FCCP, FCSHP, FAHA, FCCS, FACC, BCPS, BCCP
Professor, Pharmacy Practice
College of Pharmacy
Western University of Health Sciences
Clinical Pharmacy Specialist, Cardiology
VA Greater Los Angeles Healthcare System
Los Angeles, California 

J. Herbert Patterson, PharmD, FCCP, FHFSA
Professor of Pharmacy (Retired)
UNC Eshelman School of Pharmacy
University of North Carolina at Chapel Hill
Chapel Hill, North Carolina

Faculty Panel Chair

Kerry K. Pickworth, Pharm.D., FCCP, BCPS AQ-Cardiology
Specialty Practice Pharmacist – Cardiology
The Ohio State University Wexner Medical Center
Professor, Pharmacy Practice
The Ohio State University College of Pharmacy
Columbus, Ohio

Authors

Maya R. Chilbert, PharmD, BCCP
Clinical Assistant Professor
Department of Pharmacy Practice
Division of Outcomes and Practice Advancement (OPA)
University at Buffalo
Clinical Pharmacist
Department of Pharmacy
Buffalo General Medical Center
Buffalo, New York 

Stephanie L. Davis, Pharm.D., BCCCP, CNSC
Clinical Pharmacy Specialist, Cardiovascular Surgical ICU
Department of Pharmacy
The Johns Hopkins Hospital
Baltimore, Maryland 

Anthony J. Guarascio, Pharm.D., BCPS
Associate Professor and Division Head
Division of Pharmacy Practice
Duquesne University School of Pharmacy
Clinical Pharmacy Specialist, Infectious Diseases
Allegheny General Hospital
Pittsburgh, Pennsylvania 

Jaclyn M. Hawn, Pharm.D., BCCCP
Clinical Pharmacy Specialist - Cardiovascular ICU/Cardiothoracic Surgery
Affiliate Assistant Professor
Department of Pharmacy
Medical University of South Carolina
Charleston, South Carolina 

Gourang Patel, Pharm.D., FCCP, FCCM, BCPS, BCCCP
Director of Clinical Pharmacy Services
Department of Pharmacy
University of Chicago Medicine
Chicago, Illinois 

Sajni Patel, Pharm.D., BCCP
Clinical Pharmacy Coordinator, Cardiology
Clinical Pharmacy Specialist, Cardiac Intensive Care Unit
Department of Pharmacy
The University of Chicago Medicine
Chicago, Illinois 

Kerilyn Petrucci, Pharm.D., BCCCP
Clinical Pharmacy Specialist, Critical Care
Department of Pharmacy
University of Chicago Medicine
Chicago, Illinois 

Carolyn J. Pfeifer, Pharm.D., BCCCP
Affiliate Assistant Professor
Medical ICU Clinical Pharmacy Specialist
Department of Pharmacy
Medical University of South Carolina
Charleston, South Carolina 

Sarah Schaidle, Pharm.D., BCPS, BCCP
Cardiology Clinical Pharmacy Specialist
Department of Pharmacy
Medical University of South Carolina
Charleston, South Carolina 

Pamela Simone, Pharm.D., AACC, BCCP
Clinical Pharmacist Specialist, Cardiology
Department of Pharmacy
The University of Chicago Medicine
Chicago, Illinois 

Wesley R. Zemrak, Pharm.D., BCPS, CACP
Pharmacy Supervisor, Hemostasis & Thrombosis
Department of Pharmacy
Maine Medical Center & MaineHealth
Portland, Maine

Danielle M. Blais, Pharm.D., BCPS, BCCP
Cardiology Lead Specialty Practice Pharmacist
Department of Pharmacy
The Ohio State University Wexner Medical Center
Columbus, Ohio

Kristin I. Brower, Pharm.D., BCPS
Specialty Practice Pharmacist
Department of Pharmacy
The Ohio State University Wexner Medical Center
Columbus, Ohio 

Kristen de Almeida, Pharm.D., MSc, BCCP
Pharmacy Clinical Specialist Cardiology
Department of Pharmacy
Baptist Hospital of Miami
Miami, Florida 

Michael Barrese, Pharm.D., BCCCP, BCCP
Clinical Pharmacist Specialist
Department of Pharmacy
UPMC Central PA Region
Harrisburg, Pennsylvania 

Samuel P. Eckel, Pharm.D., BCCP, CACP
Acute Care Clinical Pharmacist
Enterprise Pharmacy Geisinger Medical Center
Danville, Pennsylvania 

Amr Mohamed Fahmi, MSc ClinPharm, BCCP
Clinical Pharmacist
Department of Pharmacy
Al Wakra Hospital/ Hamad Medical Corporation
Adjunct Clinical Instructor
College of Pharmacy
Qatar University
Doha, Qatar 

Laura A. Fuller, Pharm.D., BCPS, BCCP
Clinical Pharmacy Specialist, Cardiology
PGY1 Pharmacy Residency Director
Baptist Memorial Hospital – Desoto
Southaven, Mississippi 

Carol Heunisch, Pharm.D., BCPS, BCCP
Director, Drug Policy and Education
Department of Pharmacy
NorthShore – Edward-Elmhurst Health
Evanston, Illinois 

Benjamin A. Hohlfelder, Pharm.D., BCCCP, BCPS
Critical Care Pharmacy Clinical Specialist
Department of Pharmacy
Cleveland Clinic
Cleveland, Ohio 

Edward T. Horn, Pharm.D., BCCCP
Associate Professor
Department of Pharmacy and Therapeutics
University of Pittsburgh School of Pharmacy
Clinical Pharmacist
Heart and Vascular Institute Heart Transplant and Artificial Heart Program
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania 

Rachel Klosko, Pharm.D., BCCP
Clinical Assistant Professor
Department of Pharmacy Practice
Binghamton University
School of Pharmacy and Pharmaceutical Sciences
Johnson City, New York 

Amy Lehnert, Pharm.D., BCCP
Cardiology Clinical Pharmacy Specialist
Roper Hospital
Charleston, South Carolina 

John Lindsley, Pharm.D., BCCCP, BCCP
Clinical Pharmacy Specialist, Cardiology and Benign Hematology
Department of Pharmacy
Johns Hopkins Hospital
Baltimore, Maryland 

Melanie R. Madorsky, Pharm.D., BCPS, BCCP, BCCCP
Clinical Pharmacy Specialist, Cardiac Care Unit
Department of Pharmacy
Memorial Hermann-Texas Medical Center
Houston, Texas

Emily McElhaney, Pharm.D., BCCP
Cardiology Clinical Pharmacist
Department of Pharmacy
Cleveland Clinic
Cleveland, Ohio 

Richard H. Parrish II, Ph.D., FCCP, BCPS
Professor of Pharmacology and Medical Education
Biomedical Sciences
Mercer University
School of Medicine
Columbus, Georgia 

Megan Patel, Pharm.D., FCCM, BCCCP
Clinical Pharmacist
Department of Pharmacy
Erlanger Health System
Chattanooga, Tennessee 

A. Joshua Roberts, Pharm.D., BCPS, BCCP
Pharmacist Specialist – Cardiology
Department of Pharmacy
UC Davis Health
Sacramento, California

Alan Rozycki, Pharm.D., BCCCP
Specialty Practice Pharmacist, Cardiothoracic Surgery
The Ohio State University
Wexner Medical Center
Columbus, Ohio 

Ashley Schenk, Pharm.D., AACC, BCPS, BCCP
Cardiology Clinical Pharmacist
Department of Pharmacy UK HealthCare
Assistant Adjunct Professor
Department of Pharmacy Practice and Science
University of Kentucky College of Pharmacy
Lexington, Kentucky 

Thomas Szymanski, Pharm.D., BCCP
Clinical Pharmacy Specialist, Cardiovascular Critical Care
Department of Pharmacy
West Virginia University Medicine
Morgantown, West Virginia

Kathy Tang, Pharm.D., BCPS, BCCP
Clinical Pharmacist
Department of Pharmacy
Wellstar Kennestone Regional Medical Center
Marietta, Georgia 

Elizabeth Tesch, Pharm.D., BCPS, BCCP
Chief, Pharmacy Operations
Department of Pharmacy
United States Air Force
Eglin Air Force Base, Florida

In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company. 

An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience. 

The following persons in control of this activity’s content have relevant financial relationships: 

•          Consultancies: Jaclyn M. Hawn (ACCP); John Lindsley (LexiComp); Kerry K. Pickworth (ASHP)
•          Honoraria: John Lindsley (PharmacyTimes; ASHP)
•          Stock Ownership: Amy Lehnert (Merck&Co.);Richard H. Parrish II (Fruit Street Health);
•          Grants: Danielle M. Blais (National Institutes of Health)
•          Consultancies: Cynthia Jackevicius (AHA, CSHP);
•          Grants: Cynthia Jackevicius (Heart and Stroke Foundation of Canada) 

All other persons in control of content do not have any relevant financial relationships with an ineligible company. 

As required by the Standards of Integrity and Independence in Accredited Continuing Education, all relevant financial relationships have been mitigated prior to the CPE activity.

Activities consist of educational materials, assessments, and activity evaluations. In order to receive continuing pharmacy education credit, learners must:

• Complete the attestation statement
• Review all content
• Complete and pass the assessments
• Complete the evaluations 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity. 

ACCP and ASHP collaborate on cardiology pharmacy activities.